STOCK TITAN
  1. Home
  2. Sec-filings
  3. OPK
  4. [Form 4] Opko Health Inc. Insider Trading Activity

CEO-linked trust adds 675K OPKO Health (OPK) shares in open-market buy

Filing Impact
(Very High)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

OPKO HEALTH, INC. reported an insider-related open-market purchase of its common stock. On August 8, 2025, Frost Gamma Investments Trust, a trust entity associated with CEO and Chairman Phillip Frost, bought 675,000 shares at $1.32 per share in an indirect transaction.

Following this purchase, the filing shows 214,676,448 OPKO shares held indirectly in this trust. It also reports 3,568,951 shares held directly and 30,127,177 shares held indirectly through another related trust structure. The reporting person disclaims beneficial ownership of the trust-held securities except to the extent of any pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider FROST PHILLIP MD ET AL, Frost Gamma Investments Trust
Role CEO & Chairman | 10% Owner
Bought 675,000 shs ($891K)
Type Security Shares Price Value
Purchase Common Stock 675,000 $1.32 $891K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 214,676,448 shares (Indirect, See Footnote); Common Stock — 3,568,951 shares (Direct)
Footnotes (1)
  1. The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
FROST PHILLIP MD ET AL
(Last) (First) (Middle)
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
(Street)
MIAMI FL 33137
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OPKO HEALTH, INC. [ OPK ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO & Chairman
3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/08/2025 P 675,000 A $1.32 214,676,448 I See Footnote(1)
Common Stock 3,568,951 D
Common Stock 30,127,177 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
FROST PHILLIP MD ET AL
(Last) (First) (Middle)
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
(Street)
MIAMI FL 33137
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
X Director X 10% Owner
X Officer (give title below) Other (specify below)
CEO & Chairman
1. Name and Address of Reporting Person*
Frost Gamma Investments Trust
(Last) (First) (Middle)
OPKO HEALTH, INC.
4400 BISCAYNE BLVD.
(Street)
MIAMI FL 33137
(City) (State) (Zip)
Relationship of Reporting Person(s) to Issuer
Director X 10% Owner
Officer (give title below) Other (specify below)
Explanation of Responses:
1. The securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole shareholder of Frost-Nevada Corporation. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. These securities are held by Frost Nevada Investments Trust, of which the Reporting Person is the trustee and Frost-Nevada, L.P. is the sole and exclusive beneficiary. The Reporting Person is one of seven limited partners of Frost-Nevada, L.P. and the sole shareholder of Frost-Nevada Corporation, the sole general partner of Frost-Nevada, L.P. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Phillip Frost, M.D., Individually and as Trustee 08/08/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did OPKO Health (OPK) report in this Form 4?

OPKO Health reported an open-market purchase of 675,000 common shares at $1.32 each. The buyer was Frost Gamma Investments Trust, an entity associated with CEO and Chairman Phillip Frost, and the holding is reported as indirect ownership.

Who is attributed as buying OPKO Health (OPK) shares in this filing?

The purchase is attributed to Frost Gamma Investments Trust, not Phillip Frost personally. The trust is tied to Frost through a layered partnership structure, and the filing states that he disclaims beneficial ownership except to the extent of any pecuniary interest.

How many OPKO Health (OPK) shares were bought and at what price?

The filing shows a single open-market purchase of 675,000 OPKO Health common shares at a price of $1.32 per share. This transaction is classified as an indirect acquisition through Frost Gamma Investments Trust rather than a direct personal purchase.

What are the total indirect OPKO Health (OPK) holdings after the transaction?

After the reported trade, indirect holdings through Frost Gamma Investments Trust total 214,676,448 shares. The Form 4 also lists 30,127,177 additional shares held indirectly via another related trust structure, separate from Frost’s directly held OPKO shares.

How many OPKO Health (OPK) shares does Phillip Frost hold directly?

The Form 4 reports that 3,568,951 OPKO Health common shares are held directly. Additional large positions are held indirectly through trust and partnership entities, for which the reporting person disclaims beneficial ownership except for any pecuniary interest described in the footnotes.

What ownership disclaimers does the OPKO Health (OPK) Form 4 include?

The filing explains that trust-held OPKO shares belong to entities such as Frost Gamma Investments Trust and Frost Nevada Investments Trust. It states the reporting person disclaims beneficial ownership of those securities, except for any pecuniary interest, and that the report is not an admission of beneficial ownership.